InnoSIGN Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $22.2M

  • Investors
  • 6

InnoSIGN General Information

Description

Developer of mRNA-based pathway activity profiling technology designed to revolutionize precision medicine by obtaining more insight into the mechanisms of disease. The company offers to utilize extensive database with pathway activity profiles to support diagnostics and drug development, providing researchers with qPCR tests for decentralized use via a service testing facility.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • High Tech Campus 11
  • 5656 AE Eindhoven
  • Netherlands
+31 040
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • High Tech Campus 11
  • 5656 AE Eindhoven
  • Netherlands
+31 040

InnoSIGN Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InnoSIGN Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 26-Jul-2022 $22.2M Completed Generating Revenue
1. Spin-Off 22-Mar-2022 Completed Startup
To view InnoSIGN’s complete valuation and funding history, request access »

InnoSIGN Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of mRNA-based pathway activity profiling technology designed to revolutionize precision medicine by obtaining
Biotechnology
Eindhoven, Netherlands
18 As of 2025

Oss, Netherlands
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InnoSIGN Competitors (3)

One of InnoSIGN’s 3 competitors is RiboPro, a Venture Capital-Backed company based in Oss, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RiboPro Venture Capital-Backed Oss, Netherlands
Illumina Formerly VC-backed San Diego, CA
Qiagen Formerly VC-backed Hilden, Germany
You’re viewing 3 of 3 competitors. Get the full list »

InnoSIGN Patents

InnoSIGN Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026017877-A1 Method for determining hippo pathway activity Pending 19-Jul-2024
EP-4569139-A1 Prediction and monitoring of immunotherapy in cancer Inactive 12-Aug-2022
US-20260062755-A1 Prediction and monitoring of immunotherapy in cancer Pending 12-Aug-2022
WO-2024033063-A1 Prediction and monitoring of immunotherapy in cancer Inactive 12-Aug-2022
EP-4434034-A1 Assessment of gr cellular signaling pathway activity using mathematical modelling of target gene expression Inactive 15-Nov-2021 G16B5/00
To view InnoSIGN’s complete patent history, request access »

InnoSIGN Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnoSIGN Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brabantse Ontwikkelings Maatschappij Venture Capital Minority
Casdin Capital Venture Capital Minority
Life Science Angels Angel Group Minority
NuFund Venture Group Angel Group Minority
Rivermount VC Fund Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

InnoSIGN FAQs

  • When was InnoSIGN founded?

    InnoSIGN was founded in 2022.

  • Where is InnoSIGN headquartered?

    InnoSIGN is headquartered in Eindhoven, Netherlands.

  • What is the size of InnoSIGN?

    InnoSIGN has 18 total employees.

  • What industry is InnoSIGN in?

    InnoSIGN’s primary industry is Biotechnology.

  • Is InnoSIGN a private or public company?

    InnoSIGN is a Private company.

  • What is InnoSIGN’s current revenue?

    The current revenue for InnoSIGN is .

  • How much funding has InnoSIGN raised over time?

    InnoSIGN has raised $22.2M.

  • Who are InnoSIGN’s investors?

    Brabantse Ontwikkelings Maatschappij, Casdin Capital, Life Science Angels, NuFund Venture Group, and Rivermount VC Fund are 5 of 6 investors who have invested in InnoSIGN.

  • Who are InnoSIGN’s competitors?

    RiboPro, Illumina, and Qiagen are competitors of InnoSIGN.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process